WallStreetZenWallStreetZen

NASDAQ: PRTG
Portage Biotech Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PRTG earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$144.9M
Current Profit Margin
0%

PRTG Return on Equity

Current Company
-232.8%
Current Industry
-63.5%
Current Market
188%
PRTG's Return on Equity (-232.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PRTG announces earnings.

PRTG Return on Assets

Current Company
-171%
Current Industry
2.9%
PRTG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PRTG Return on Capital Employed

Current Company
-367.8%
Current Industry
19.5%
PRTG's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRTG vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PRTG$0.00-$170.35M-$144.91MN/AN/A
THAR$0.00-$9.30M-$9.32MN/AN/A
NEXI$0.00-$30.78M-$32.34MN/AN/A
ZVSA$0.00-$107.74M-$106.25MN/AN/A
TCBP$0.00-$8.05M-$7.57M-100.00%N/A
View Top Biotech Stocks

PRTG earnings dates

Next earnings date
May 29, 2024

Portage Biotech Earnings & Revenue FAQ

What were PRTG's earnings last quarter?

On Invalid Date, Portage Biotech (NASDAQ: PRTG) reported Q4 2023 earnings per share (EPS) of -$1.88, up 327.27% year over year. Total Portage Biotech earnings for the quarter were -$39.38 million. In the same quarter last year, Portage Biotech's earnings per share (EPS) was -$0.44.

If you're new to stock investing, here's how to buy Portage Biotech stock.

What was PRTG's earnings growth in the past year?

As of Q2 2024, Portage Biotech's earnings has grown year over year. Portage Biotech's earnings in the past year totalled -$144.91 million.

What is PRTG's earnings date?

Portage Biotech's earnings date is Invalid Date. Add PRTG to your watchlist to be reminded of PRTG's next earnings announcement.

What was PRTG's revenue last quarter?

On Invalid Date, Portage Biotech (NASDAQ: PRTG) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Portage Biotech's revenue was $0.00.

What was PRTG's revenue growth in the past year?

As of Q2 2024, Portage Biotech's revenue has grown null year over year. Portage Biotech's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.